The Metal Theory of Alzheimer's Disease

被引:258
|
作者
Bush, Ashley I. [1 ]
机构
[1] Univ Melbourne, Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia
关键词
Alzheimer's disease; amyloid; copper; iron; presenilin; tau; zinc; PLACEBO-CONTROLLED TRIAL; A-BETA; TRANSGENIC MICE; SENILE PLAQUES; DOUBLE-BLIND; IRON-EXPORT; ZINC; COPPER; ACCUMULATION; PBT2;
D O I
10.3233/JAD-2012-129011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain homeostasis of transition metals is severely perturbed in Alzheimer's disease (AD), with extracellular pooling of zinc and copper in amyloid, and intraneuronal accumulation of iron. Rapidly accumulating evidence indicates that these perturbances themselves may contribute significantly to the cognitive loss and neurodegeneration, even in the absence of AD proteopathy. There is now strong evidence that each of the major protein participants in AD pathology has physiologically important interactions with transition metals: A beta PP is the neuronal iron export ferroxidase with a major interaction with ferroportin, presenilins are needed for the import of approximate to 50% of cellular copper and zinc, and tau promotes the export of neuronal iron by facilitating the trafficking of A beta PP to the surface. Therefore, amyloid and tau pathology arise in a milieu of constitutively high metal flux, and the major components of AD pathology may contribute to the disease by failing in their metal transport roles.
引用
收藏
页码:S277 / S281
页数:5
相关论文
共 50 条
  • [31] The role of metals in the etiology of Alzheimer's disease
    Shcherbatykh, Ivan
    Carpenter, David O.
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (02) : 191 - 205
  • [32] The inorganic perspectives of neurotrophins and Alzheimer's disease
    Travaglia, Alessio
    Pietropaolo, Adriana
    La Mendola, Diego
    Nicoletti, Vincenzo Giuseppe
    Rizzarelli, Enrico
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 111 : 130 - 137
  • [33] Alzheimer's disease & metals: therapeutic opportunities
    Kenche, Vijaya B.
    Barnham, Kevin J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (02) : 211 - 219
  • [34] Copper and Ceruloplasmin Abnormalities in Alzheimer's Disease
    Brewer, George J.
    Kanzer, Steve H.
    Zimmerman, Earl A.
    Celmins, Dzintra F.
    Heckman, Susan M.
    Dick, Robert
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (06): : 490 - 497
  • [35] Biometals and Their Therapeutic Implications in Alzheimer’s Disease
    Scott Ayton
    Peng Lei
    Ashley I. Bush
    Neurotherapeutics, 2015, 12 : 109 - 120
  • [36] Metals and amyloid-β in Alzheimer's disease
    Maynard, CJ
    Bush, AI
    Masters, CL
    Cappai, R
    Li, QX
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 147 - 159
  • [37] A Bioinorganic View of Alzheimer's Disease: When Misplaced Metal Ions (Re)direct the Electrons to the Wrong Target
    Faller, Peter
    Hureau, Christelle
    CHEMISTRY-A EUROPEAN JOURNAL, 2012, 18 (50) : 15910 - 15920
  • [38] Rebalancing metal dyshomeostasis for Alzheimer's disease therapy
    Yang, Guan-Jun
    Liu, Hao
    Ma, Dik-Lung
    Leung, Chung-Hang
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2019, 24 (08): : 1159 - 1170
  • [39] Heavy Metals and Essential Metals Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
    Babic Leko, Mirjana
    Mihelcic, Matej
    Jurasovic, Jasna
    Nikolac Perkovic, Matea
    Spanic, Ena
    Sekovanic, Ankica
    Orct, Tatjana
    Zubcic, Klara
    Langer Horvat, Lea
    Pleic, Nikolina
    Kidemet-Piskac, Spomenka
    Vogrinc, Zeljka
    Pivac, Nela
    Diana, Andrea
    Borovecki, Fran
    Hof, Patrick R.
    Simic, Goran
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [40] Iron Chelators and Alzheimer's Disease Clinical Trials
    Mandal, Pravat K.
    Maroon, Joseph C.
    Samkaria, Avantika
    Arora, Yashika
    Sharma, Shallu
    Pandey, Ashutosh
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 : S243 - S249